Invivo Therapeutics Holdings Corp (OTCMKTS: NVIV) and Dynatronics Corporation (NASDAQ:DYNT) are both small-cap healthcare companies, but which is the better investment? We will contrast the two businesses based on the strength of their valuation, analyst recommendations, profitability, earnings, dividends, risk and institutional ownership.

Profitability

This table compares Invivo Therapeutics Holdings Corp and Dynatronics Corporation’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Invivo Therapeutics Holdings Corp N/A -118.45% -96.82%
Dynatronics Corporation -5.47% -88.57% -9.59%

Earnings and Valuation

This table compares Invivo Therapeutics Holdings Corp and Dynatronics Corporation’s revenue, earnings per share and valuation.

Gross Revenue Price/Sales Ratio EBITDA Earnings Per Share Price/Earnings Ratio
Invivo Therapeutics Holdings Corp N/A N/A -$25.77 million N/A N/A
Dynatronics Corporation $32.72 million 0.25 -$261,530.00 ($1.24) -1.82

Dynatronics Corporation has higher revenue and earnings than Invivo Therapeutics Holdings Corp.

Insider and Institutional Ownership

18.2% of Dynatronics Corporation shares are owned by institutional investors. 47.6% of Dynatronics Corporation shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Analyst Ratings

This is a summary of current recommendations and price targets for Invivo Therapeutics Holdings Corp and Dynatronics Corporation, as reported by MarketBeat.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Invivo Therapeutics Holdings Corp 0 1 0 0 2.00
Dynatronics Corporation 0 0 0 0 N/A

Invivo Therapeutics Holdings Corp presently has a consensus target price of $6.00, suggesting a potential upside of 313.79%. Given Invivo Therapeutics Holdings Corp’s higher possible upside, equities research analysts clearly believe Invivo Therapeutics Holdings Corp is more favorable than Dynatronics Corporation.

Summary

Dynatronics Corporation beats Invivo Therapeutics Holdings Corp on 6 of the 8 factors compared between the two stocks.

About Invivo Therapeutics Holdings Corp

InVivo Therapeutics Holdings Corp., formerly Design Source, Inc., is a research and clinical-stage biomaterials and biotechnology company. The Company is engaged in developing and commercializing biopolymer-scaffolding devices for the treatment of spinal cord injuries (SCI). The Company’s approach to treating acute SCIs is based on its investigational Neuro Spinal Scaffold implant, an investigational bioresorbable polymer scaffold that is designed for implantation at the site of injury within a spinal cord contusion and is intended to treat acute spinal cord injury. The Neuro-Spinal Scaffold consists of biocompatible and bioresorbable polymers, which include poly lactic-co-glycolic acid (PLGA) and Poly-L-Lysine (PLL). The Company is also evaluating other technologies and therapeutics that may be complementary to its development of the Neuro-Spinal Scaffold implant. The Company has a clinical development program for acute SCI and a preclinical development program for chronic SCI.

About Dynatronics Corporation

Dynatronics Corporation is a manufacturer and distributor of physical medicine products. The Company’s products include a line of medical equipment for physical medicine applications, including therapy devices, medical supplies and soft goods, treatment tables and rehabilitation equipment. Its products are used by physical therapists, chiropractors, sports medicine practitioners, podiatrists, physicians and other physical medicine professionals. Its physical medicine products include therapeutic modalities, such as Dynatron Solaris, including electrotherapy and thermal therapy, and 25 Series, including electrotherapy and ultrasound; manufactured capital products, including traction systems and wood furniture; manufactured supplies, including cold packs, straps, wedges, bolsters and mats; distributed capital products, including hydrotherapy, weight training equipment and pilates, and distributed supplies, including clinical accessories, sports med and taping products, lotions and gels.

Receive News & Stock Ratings for Invivo Therapeutics Holdings Corp Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Invivo Therapeutics Holdings Corp and related stocks with our FREE daily email newsletter.